Market Research Logo

The World Liquid Biopsy Market

The World Liquid Biopsy Market

Liquid biopsies are a set of minimally invasive diagnostic methods that analyze tumor-derived materials that can be found circulating in biological fluids, to provide information for the diagnosis, treatment, and monitoring of cancer.

This report, The World Liquid Biopsy Market, from Kalorama Information, contains up-to-date information and useful data points for business planning:

  • Research vs. Clinical Liquid Biopsy
  • The Market for Liquid Biopsy by Region
  • The Market for Liquid Biopsy Market by Type of Analyte
  • The Market for CTC-based Liquid Biopsy
  • The Market for ctDNA-based Liquid Biopsy
  • The Market for EV and Exosome-based Liquid Biopsy
  • The Market for Multi-Analyte-based Liquid Biopsy
  • The Market for Other Liquid Biopsy
  • Liquid Biopsy Market by Type of Cancer (Breast, Lung, Colorectal, Ovarian, Prostate, Pan-Cancer, Other Cancer)
  • Selected ctDNA-based Liquid Biopsy Tests in Development
  • Selected Market-Available CTC-based Liquid Biopsy Tests, 2019
  • Selected Liquid Biopsy Tests That Assess Multiple Analytes, 2019
While tissue biopsies and imaging techniques remain the current standards of care in the diagnosis of solid tumors, they have risks and limitations and limitations, some of which can be overcome by the use of liquid biopsy in clinical oncology, as an alternative or complementary technique to the current standards of care.

Liquid biopsy testing has many potential applications in aspects of clinical oncology, including:
  • Early detection and diagnosis / screening
  • Alternative testing method when tissue biopsy is difficult/impossible, or when the primary site of metastatic disease is unknown
  • Therapy personalization and monitoring – by molecular characterization of a patient’s disease, clinicians can select the optimal course of therapy and monitor efficacy over time, as well as quickly react to adjust therapy should treatment resistance arise
  • Disease monitoring – to observe disease progression, tumor evolution, residual disease, and early detection of recurrence
  • Prognosis of disease


  • Executive Summary
    • Introduction
    • Liquid Biopsy Technologies
    • Industry Structure
    • Liquid Biopsy Market Revenues and Forecast
      • Table Global Liquid Biopsy Market by Geographic Region, 2016 (%)
      • Table Global Liquid Biopsy Market Forecast by Region ($ millions), 2018-2023
  • Liquid Biopsy Technologies
    • Introduction
      • Table Comparison of Tissue and Liquid Biopsy
    • Current Major Liquid Biopsy Technologies
      • Table Advantages and Limitations of Major Liquid Biopsy Technologies
  • Circulating Tumor DNA (ctDNA) Liquid Biopsy
    • Introduction
    • Advantages and Limitations of ctDNA in Liquid Biopsy
    • Current ctDNA-based Liquid Biopsy Tests
      • Table Selected Market-Available ctDNA-based Liquid Biopsy Tests, 2019
      • Biocartis
      • Biocept
      • Biodesix
      • CellMax Life
      • Circulogene
      • Diacarta
      • Epigenomics
      • Foundation Medicine
      • Guardant Health
      • Inivata
      • LungLife AI
      • Myriad Genetics
      • NeoGenomics
      • OncoDNA
      • Personal Genomic Diagnostics
      • QIAGEN
      • Resolution Biosciences
      • Roche Diagnostics
      • Sysmex-Inostics
    • ctDNA-based Liquid Biopsy Tests in Development
      • Table Selected ctDNA-based Liquid Biopsy Tests in Development
      • Exact Sciences
      • Freenome
      • GRAIL
      • Personal Genome Diagnostics
      • Tempus
  • Circulating Tumor Cells (CTCs) Liquid Biopsy
    • Introduction
    • Challenges in the Development of CTC-based Liquid Biopsy Tests
    • CTC-based Liquid Biopsy Tests
      • Table Selected Market-Available CTC-based Liquid Biopsy Tests, 2019
      • Adaptive Biotechnologies
      • Biocept
      • CellMax Life
      • Epic Sciences
      • GILUPI
      • LungLife AI
      • Menarini-Silicon Biosystems
      • QIAGEN
    • CTC-based Liquid Biopsy Tests in Development
      • Table Selected CTC-based Liquid Biopsy Tests in Development, 2019
      • ANGLE
      • Epic Sciences
      • Liquid Biotech USA
  • Extracellular Vesicles and Other Liquid Biopsy
    • Introduction
    • Liquid Biopsy Tests Based on Extracellular Vesicles / Other Analytes
      • Table Selected Market-Available Liquid Biopsy Tests based on Extracellular Vesicles / Other Analytes, 2019
      • Biodexis
      • Exosome Diagnostics
      • Hologic
      • MDxHealth
      • Vermillion
    • Extracellular Vesicle/Other Analyte-based Liquid Biopsy Tests in Development
      • Table Selected Extracellular Vesicle/Other Analyte-based Liquid Biopsy Tests in Development, 2019
      • Circulogene
      • OncoCyte
      • QIAGEN
      • Resolution Biosciences
      • VolitionRx
  • Multi-Analyte Liquid Biopsy Tests
    • Introduction
    • Liquid Biopsy Tests Based on Multiple Analytes
      • Table Selected Liquid Biopsy Tests That Assess Multiple Analytes, 2019
      • Biocept
      • Biodesix
      • Foundation Medicine
      • LungLife AI
      • NeoGenomics
      • OncoDNA
    • Multiple Analyte-based Liquid Biopsy Tests in Development
      • Table Selected Multi Analyte-based Liquid Biopsy Tests in Development, 2019
      • Exact Sciences
      • Freenome
      • GRAIL
      • LungLife AI
  • Liquid Biopsy Tests for Research Use Only
    • Introduction
    • Liquid Biopsy Tests for Research Use Only
      • Table Selected Liquid Biopsy Tests for Research Use Only, 2019
      • Agena Bioscience
      • ANGLE
      • DiaCarta
      • Exosome Diagnostics
      • Guardant Health
      • Natera
      • QIAGEN
  • Liquid Biopsy Industry Analysis
    • Introduction
    • Tiers of Competition
      • Table Selected Participants in the Liquid Biopsy Market, 2019
    • Competitive Factors
    • Significant Market Trends
      • Table Significant Trends in the Liquid Biopsy Market, 2019
      • Personalized Medicine
      • Increasing Global Life Expectancy
      • New Liquid Biopsy Products
      • Increasing Accessibility of Genetic Testing
        • Table Laboratory Testing Sites - Tests Performed by Vendor vs. Testing Performed by Outside Labs (%)
      • Regulatory Hurdles
      • Third-Party Payor Coverage
      • Demonstrated Clinical Utility
      • Incidence Rates of Specific Cancers
    • Competitors No Longer in the Liquid Biopsy Market
      • Table Summary of Companies That Have Exited the Liquid Biopsy Market
  • Liquid Biopsy Market
    • Market Overview
      • Table Global Liquid Biopsy Diagnostics Market Estimate by Analyte, 2018 (%)
      • Table Global Liquid Biopsy Diagnostics Market Estimate by Region, 2018 (%)
      • Table Global Liquid Biopsy Market Estimate by Type of Use, (Research Use, Clinical Diagnostics Use) 2018 (%)
      • Table Global Liquid Biopsy Market by Test Performance Model (In-House Labs, Outside Clinical Labs, Both Options Available) (%)
    • Market Forecast
      • Table Global Liquid Biopsy Market Forecast by Region - North America, Europe, Asia Pacific, Rest of World, World ($ millions), 2018-2023
      • Table Global Liquid Biopsy Market Forecast by Region - North America, Europe, Asia Pacific, Rest of World ( $ millions), 2018-2023
  • Market by Analyte
    • Circulating Tumor DNA
      • Market Overview
      • Revenue Forecast
        • Table Global Liquid Biopsy Market for ctDNA ($ millions), 2018-2023
    • Circulating Tumor Cells
      • Market Overview
      • Revenue Forecast
        • Table Global Liquid Biopsy Market for CTCs ($ millions), 2018-2023
    • Extracellular Vesicles and Other Analytes
      • Market Overview
      • Revenue Forecast
        • Table Global Liquid Biopsy Market for Extracellular Vesicles ($ millions), 2018-2023
    • Multiple Analytes
      • Market Overview
      • Revenue Forecast
        • Table Global Liquid Biopsy Market for Multiple Analytes ($ millions), 2018-2023
  • Market by Application
    • Therapy Guidance and Monitoring
      • Market Overview
      • Revenue Forecast
        • Table Liquid Therapy for Therapy Guidance ($ millions), 2018-2023
    • Diagnosis/Screening
      • Market Overview
      • Revenue Forecast
        • Table Global Liquid Biopsy Market for Diagnosis and Screening ($ millions), 2018-2023
    • Disease Prognosis
      • Market Overview
      • Revenue Forecast
        • Table Global Liquid Biopsy Market for Disease Prognosis ($ millions), 2018-2023
  • Market by Cancer Type
    • Breast Cancer
      • Market Overview
      • Revenue Forecast
        • Table Global Liquid Biopsy Market for Breast Cancer ($ millions), 2018-2023
    • Colorectal Cancer
      • Market Overview
      • Revenue Forecast
        • Table Global Liquid Biopsy Market for Colorectal Cancer ($ millions), 2018-2023
    • Lung Cancer
      • Market Overview
      • Revenue Forecast
        • Table Global Liquid Biopsy Market for Lung Cancer ($ millions), 2018-2023
    • Ovarian Cancer
      • Market Overview
      • Revenue Forecast
        • Table Global Liquid Biopsy Market for Ovarian Cancer ($ millions), 2018-2023
    • Prostate Cancer
      • Market Overview
      • Revenue Forecast
        • Table Global Liquid Biopsy Market for Prostate Cancer ($ millions), 2018-2023
    • Other Cancers
      • Market Overview
      • Revenue Forecast
        • Table Global Liquid Biopsy Market for Other Cancers ($ millions), 2018-2023
    • Pan-Cancer Tests
      • Market Overview
      • Revenue Forecast
        • Table Global Liquid Biopsy Market for Pan-Cancer Testing ($ millions), 2018-2023
  • Liquid Biopsy Company Profiles
    • Top Ten Companies in the Liquid Biopsy Market
      • Table Top Ten Companies in the Liquid Biopsy Market
    • Adaptive Biotechnologies
    • Agena Bioscience, Inc.
    • ANGLE, plc
    • Biocartis Group NV
    • Biocept, Inc.
    • Biodesix
    • CellMax Life
    • Circulogene
    • DiaCarta, Inc.
    • Epic Sciences
    • Epigenomics AG
    • Exact Sciences
    • Exosome Diagnostics, Inc.
    • Foundation Medicine, Inc.
    • Freenome, Inc.
    • Genomic Health, Inc.
    • GILUPI GmbH
    • GRAIL
    • Guardant Health, Inc.
    • Hologic
    • Inivata
    • Liquid Biotech USA
    • LungLife AI (formerly Cynvenio Biosystems)
    • MDxHealth
    • Menarini-Silicon Biosystems, Spa
    • Myriad Genetics, Inc.
    • Natera, Inc.
    • NeoGenomics Laboratories, Inc.
    • OncoCyte Corporation
    • OncoDNA S.A.
    • Personal Genome Diagnostics
    • QIAGEN N.V.
      • Cell-free DNA Technologies
      • CTC Technologies
      • Exosome and miRNA Technologies
    • Resolution Biosciences
    • Roche Diagnostics
    • Sysmex-Inostics, Inc.
    • Tempus
    • Vermillion, Inc.
    • VolitionRx

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report